Acm Research (ACMR) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
782.1M
Gross Profit
391.6M
50.06%
Operating Income
151.0M
19.31%
Net Income
131.3M
16.78%
Balance Sheet Metrics
Total Assets
1.9B
Total Liabilities
759.8M
Shareholders Equity
1.1B
Debt to Equity
0.69
Cash Flow Metrics
Operating Cash Flow
86.6M
Free Cash Flow
66.5M
Revenue & Profitability Trend
Acm Research Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 782.1M | 557.7M | 388.8M | 259.8M | 156.6M |
| Cost of Goods Sold | 390.6M | 281.5M | 205.2M | 144.9M | 87.0M |
| Gross Profit | 391.6M | 276.2M | 183.6M | 114.9M | 69.6M |
| Operating Expenses | 240.6M | 180.4M | 124.6M | 76.2M | 48.1M |
| Operating Income | 151.0M | 95.8M | 59.0M | 38.7M | 21.5M |
| Pre-tax Income | 166.3M | 116.2M | 67.4M | 43.1M | 19.3M |
| Income Tax | 35.0M | 19.4M | 16.8M | 134.0K | -2.4M |
| Net Income | 131.3M | 96.9M | 50.6M | 42.9M | 21.7M |
| EPS (Diluted) | - | $1.16 | $0.59 | $0.58 | $0.30 |
Income Statement Trend
Acm Research Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 1.5B | 1.2B | 963.8M | 952.9M | 260.7M |
| Non-Current Assets | 372.3M | 314.8M | 271.7M | 99.2M | 80.6M |
| Total Assets | 1.9B | 1.5B | 1.2B | 1.1B | 341.3M |
| Liabilities | |||||
| Current Liabilities | 641.2M | 500.7M | 396.2M | 205.9M | 102.9M |
| Non-Current Liabilities | 118.6M | 64.1M | 27.1M | 34.6M | 30.2M |
| Total Liabilities | 759.8M | 564.7M | 423.3M | 240.5M | 133.1M |
| Equity | |||||
| Total Shareholders Equity | 1.1B | 926.2M | 812.2M | 811.7M | 208.2M |
Balance Sheet Composition
Acm Research Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 131.3M | 96.9M | 50.6M | 42.9M | 21.7M |
| Operating Cash Flow | 86.6M | -88.0M | -92.9M | -40.2M | -3.3M |
| Investing Activities | |||||
| Capital Expenditures | -82.5M | -61.9M | -91.1M | -9.2M | -45.4M |
| Investing Cash Flow | -8.5M | -4.3M | -437.7M | -12.3M | -60.4M |
| Financing Activities | |||||
| Dividends Paid | -6.9M | -4.0M | 0 | 0 | - |
| Financing Cash Flow | 49.1M | -42.7M | 35.3M | 493.7M | 9.9M |
| Free Cash Flow | 66.5M | -139.7M | -154.7M | -49.8M | -69.0M |
Cash Flow Trend
Acm Research Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.72
Forward P/E
12.66
Price to Book
1.66
Price to Sales
1.96
PEG Ratio
12.66
Profitability Ratios
Profit Margin
13.28%
Operating Margin
14.96%
Return on Equity
12.68%
Return on Assets
5.43%
Financial Health
Current Ratio
2.46
Debt to Equity
20.53
Beta
1.48
Per Share Data
EPS (TTM)
$1.57
Book Value per Share
$14.86
Revenue per Share
$12.80
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| acmr | 1.6B | 15.72 | 1.66 | 12.68% | 13.28% | 20.53 |
| Applied Materials | 138.0B | 20.92 | 7.28 | 36.37% | 24.06% | 35.18 |
| Lam Research | 117.2B | 25.52 | 12.36 | 53.14% | 27.19% | 47.15 |
| Axcelis | 2.1B | 12.18 | 2.08 | 18.45% | 18.58% | 7.05 |
| Kulicke & Soffa | 1.9B | 94.92 | 2.16 | 2.29% | 3.11% | 4.20 |
| Veeco Instruments | 1.2B | 19.60 | 1.49 | 8.51% | 8.99% | 35.41 |
Financial data is updated regularly. All figures are in the company's reporting currency.